Bicycle Therapeutics (BCYC) Leases (2019 - 2026)

Bicycle Therapeutics (BCYC) has 8 years of Leases data on file, last reported at $14.5 million in Q1 2026.

• For the quarter ending Q1 2026, Leases rose 116.55% year-over-year to $14.5 million; the trailing twelve-month figure through Mar 2026 stood at $14.5 million (up 116.55% YoY), and the FY2025 full-year result was $15.9 million, up 107.04% from the prior year.
• Leases for Q1 2026 stood at $14.5 million, down from $15.9 million in the prior quarter.
• Across five years, Leases topped out at $18.7 million in Q1 2023 and bottomed at $4.6 million in Q3 2025.
• The 5-year median for Leases is $13.5 million (2022), against an average of $12.3 million.
• The widest annual swing landed in 2022, when Leases soared 350.15%; it then sank 49.82% in 2025.
• A 5-year view of Leases shows it stood at $13.7 million in 2022, then slipped by 3.58% to $13.2 million in 2023, then slumped by 41.73% to $7.7 million in 2024, then jumped by 107.04% to $15.9 million in 2025, then declined by 8.5% to $14.5 million in 2026.
• The last three Leases figures came in at $14.5 million (Q1 2026), $15.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.

Peer Comparison